Skip to main content
Premium Trial:

Request an Annual Quote

Chugai Extends Deal for Use of Genedata Software

NEW YORK (GenomeWeb News) – Genedata today said that Japanese drug firm Chugai Pharmaceutical is extending its licensing agreement for use of the Genedata Expressionist software.

Chugai uses the product to streamline R&D processes and for enterprise-wide analysis and management of microarray data. Moving ahead, the company plans to use the software to analyze data for personalized medicine. In a statement, Junichi Muroya, of Chugai's bioinformatics department, said that in addition to day-to-day analysis, the company will explore using the software for next-generation sequencing.

Financial and other terms of the extension were not disclosed.

Chugai has used Genedata's software since at least 2007 to analyze high-throughput screening data.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.